Acthar and Stomatitis - a phase IV clinical study of FDA data

Summary:

Stomatitis is reported as a side effect among people who take Acthar (corticotropin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Humira, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Stomatitis when taking Acthar. It is created by eHealthMe based on reports of 4,932 people who have side effects when taking Acthar from the FDA, and is updated regularly.

What is Acthar?

Acthar has active ingredients of corticotropin. eHealthMe is studying from 4,948 Acthar users. Check the latest studies of Acthar.

What is Stomatitis?

Stomatitis (inflammation of mucous membrane of mouth) is found to be associated with 1,879 drugs and 2,011 conditions by eHealthMe. Check the latest studies of Stomatitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

4,932 people reported to have side effects when taking Acthar.
Among them, 18 people (0.36%) have Stomatitis.

Among these 18 people:

How long have people been on Acthar when they have Stomatitis? *

What is the gender of people who have Stomatitis when taking Acthar? *

female: 94.44 %
male: 5.56 %

What is the age of people who have Stomatitis when taking Acthar? *

What are other drugs people take besides Acthar? *

What are other side effects people have besides Stomatitis? *

Diarrhea: 7 people, 38.89%
Swelling: 7 people, 38.89%
Abdominal Distension: 7 people, 38.89%
Rashes (redness): 7 people, 38.89%
Insomnia (sleeplessness): 7 people, 38.89%
Blood Glucose Increased: 6 people, 33.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 33.33%
Urinary Tract Infection: 6 people, 33.33%
Drug Intolerance (drug sensitivity): 6 people, 33.33%
Visual Impairment: 6 people, 33.33%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 44.44%
Urinary Tract Infection: 6 people, 33.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 16.67%
Swelling: 2 people, 11.11%
Diarrhea: 2 people, 11.11%
Abdominal Distension: 2 people, 11.11%
Osteoporosis (bones weak and more likely to break): 1 person, 5.56%
Optic Neuritis (optic nerve inflammation): 1 person, 5.56%
Itching: 1 person, 5.56%
Dry Eyes (lack of adequate tears): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Acthar and have Stomatitis?

- Check whether Stomatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acthar:

Acthar (4,948 reports)

Stomatitis treatments and more:

Stomatitis (75,938 reports)

Browse all side effects of Acthar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stomatitis:

Stomatitis (1,879 drugs)

Browse all the conditions that are associated with Stomatitis:

Stomatitis (2,011 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on corticotropin (the active ingredients of Acthar) and Acthar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.